NIFTY 50

Buy Aurobindo Pharma, Cipla, ICICI Bank & TCS, says VK Sharma of HDFC Securities

Updated : April 30, 2019 09:12 AM IST

The latest analysis and commentary by stock market guru VK Sharma of HDFC Securities on what is moving the markets today.

He also spoke at length on Aurobindo Pharma, Cipla, ICICI Bank, Reliance Industries and Tata Consultancy Services (TCS).

"Pharma stocks are stocks which we like. Aurobindo Pharma is the first one which we are buying, a tad lower because it had run-up more than 4 percent yesterday so I am buying the 840 Call at around Rs 25 it had closed at Rs 29 I am buying at Rs 25 stop loss at Rs 20 target around Rs 25. Cipla is another stock where we saw positions being build to the extent of 5 percent. I am buying the Rs 580 Call at around Rs 16.5 a small stop loss at Rs 13 and target around Rs 25. ICICI Bank happens to be my pick in the banking sector. We have seen 3 percent stock rolls on Friday. Buying the 410 Call at Rs 15.6 stop loss at Rs 12 target of around Rs 23.”

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV